FIGURE

Fig. 6

ID
ZDB-FIG-220906-6
Publication
Colijn et al., 2022 - High-throughput methodology to identify CRISPR-generated Danio rerio mutants using fragment analysis with unmodified PCR products
Other Figures
All Figure Page
Back to All Figure Page
Fig. 6

Fig. 6. Cluap1stl839 mutants display body axis symmetry defects that are inherited at the Mendelian ratio and correspond to homozygosity of the mutant allele. (A) Representative images of control sibling and cluap1stl839/stl839 homozygous mutants at 4 dpf. Mutants display body curvature. (B) This curvature is present in 24.3% of total embryos, which suggests Mendelian inheritance of the mutant allele. (Statistics: Chi-square, observed vs. expected, p ​= ​0.75). (C) Image of the fragment analyzer gel output data. Lane ‘+’ is the positive heterozygous control for the 6-bp indel; lane ‘–‘ is the negative control. Lanes 1–14 are F2 embryos bred from an incross between F1 adult cluap1stl839/+ carriers with the 6-bp indel. Lanes 1–7 represent embryos that look phenotypically normal. There is a combination of heterozygous (1–5) and homozygous wildtype (6, 7) alleles in the phenotypically normal group. Lanes 8–14 represent embryos with body curvature. All embryos with curved bodies genotype as homozygous mutants. Notice the slight variability between the sizing of bands in Lanes 1 and 12 compared to similar genotypes. Since each lane is run independently through an individual single capillary, there is a possibility for small sizing shifts between consecutive wells.

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image.

Reprinted from Developmental Biology, 484, Colijn, S., Yin, Y., Stratman, A.N., High-throughput methodology to identify CRISPR-generated Danio rerio mutants using fragment analysis with unmodified PCR products, 22-29, Copyright (2022) with permission from Elsevier. Full text @ Dev. Biol.